Printer Friendly

Insight into the DNA repair mechanism operating during cell cycle checkpoints in eukaryotic cells.


In everyday life, 1000 to 100,000 DNA damage incidences occur in the cell per day (Lodish et al., 2004). A wide variety of damages are caused by environmental agents, such as UV radiation released by sunlight, IR, and numerous genotoxic chemicals can damage the DNA. In addition, the genome is also threatened with by-products of normal cellular metabolism, such as reactive oxygen species which is derived from oxidative respiration and products of lipid peroxidases (Lindahl et al., 1999). In response to these agents a variety of damages occurs in the DNA such as single and double strand breaks, mismatches, and chemical adducts (Figure 1). Therefore, cell has to develop a multiple repair pathway by forming numerous protein cascade events in order to repair the damage as accurately as possible (Nasmyth et al., 1996).

1. Cell cycle checkpoints

All eukaryotic cells have four different phases in cell cycle: G1-phase, S-phase, G2 and M-phase and one phase outside the cell cycle, G-0 (Figure 2). In mammalian somatic cells the phases are well-defined and represent stages in the life of a cell in which distinct biochemical reactions take place (Sancar et al., 2004). The overall length of the cell cycle in cultured mammalian cells is between 18 to 24 hours. A typical G1 phase lasts 8-10 hours whereas the embryonic cells spend only a few minutes in G1. During G1 phase, the internal and external signals together determine whether the cell undergoes a round of duplication. Once the cell passes the restriction point by following S-phase DNA replication must be completed after that reversal is not possible.



In the G2-phase, the cell confirms that it is ready to proceed to the subsequent M-phase where the duplicated chromosomes are segregated in less than one hour. If a cell lacks nutrients in the G1-phase, it enters transiently into a resting G0-phase (Figure 2). However, they may stay in this state for hours, days, weeks or even years before they start dividing again or even stay in G0 permanently until the organism dies (Becker et al., 2006).

1.1 Molecular component of cell cycle checkpoint

Recent studies in yeast and human cells show that many proteins sense the DNA damage; these include sensor proteins, signal transducer proteins and effector proteins. These effector proteins launch a cascade of events which mediate cell cycle arrest, apoptosis, DNA repair, and activation of damage induced transcription programs (Table 1).
Table 1: Schematic representation of DNA
damage checkpoint protein homologs in different eukaryotes.

Protein function      S.cerevisiae  S.pombe  Xenopus  Mammals

Sensors               Rad24         Rad17    Rad17    Rad17
RFC-like              Ddc1          Rad9     Rad9     Rad9
PCNA-like             Mec3          Hus1     Hus1     Hus1
                      Rad17         Rad1     Rad1     Rad1
P13-Kinases (PIKK)    Tel1          Tel1     ATM      ATM
                      Med           Rad3     ATR      ATR
PIKK binding partner  Ddc2          Rad26    ???      ATRIP
Mediators             Rad9          Crb2     ???      BRCA1???
                      Mrc1          Mrc1     Claspin  Claspin
Effector kinases      Rad53         Cds1     Cds1     Chk2
                      Chk1          Chk1     Chk1     Chk1

1.1.1 Sensors and their role in repair mechanism

The first group of proteins that have been found to function as sensors consists of proliferating cell nuclear antigen (PCNA) and replication factor-C (RFC). The candidate DNA damage sensors Rad9, Hus1, and Rad1 form a ring structure (the "9-1-1" complex) that can encircle the DNA similar to PCNA (Melo and Toczyski, 2002). Upon DNA damage both of these protein rings load on DNA for instance, during replication PCNA is loaded on the DNA by RFC complex which consists of five subunits (RFC[sub.1-5]) and the 9-1-1 complex is loaded on damaged DNA by a protein complex that consists of four subunits (RFC[sub.2-5]) and Rad17, forming the Rad17 -RFC [sub.2-5] complexes. As soon as the 9-1-1 complex is bound to the damaged DNA, it is expected to form a scaffold for downstream checkpoint and repair proteins. One of the recent recognized sensor protein complexes that regulates DNA damage repair is MRE11 complex consist of meiotic recombination 11 (MRE11), Rad50, Nijmegen Breakage Syndrome 1 (NBS1) (Petrini and Stracker, 2003). Recent studies on the structure and function of MRE11 complex have suggested that this complex protein plays an important role in downstream target for DSB (Houtgraaf et al., 2006).

1.1.2 Signal transducers

Signal transducers are another group of protein players in the early response of DNA damage. They consist of ataxia telangiectasa (AT) mutated AT (ATM) and Rad3 related AT (ATR) (Figure 3). Studies have shown that mutation in ATM causes an autosomal recessive disorder, characterized by immunodeficiency, neurological disorders, and high cancer predisposition (Shiloh et al., 1997). Electron microscopy has revealed that ATM binds to DNA in monomeric form and upon exposure to ionizing radiation ATM phosphorylates many proteins, including Chk2, p53, NBS1, and BRCA1 (Cortez et al., 1999). ATR was identified later on the basis of sequence and functional homology to ATM (Cimprich et al., 1996). Results from de Klein et al. (2000) show that knockout of ATR in mice resulted in embryonic lethality and mutations that caused loss of ATR activity in humans have been associated with the human autosomal recessive disorder, Seckel syndrome. These suggest that ATR also functions in essential cellular processes in damaged cells like DNA replication and cellular differentiation.

1.1.3. Mediators

In addition to sensors, signal transducers, effector proteins and many other proteins are involved in the DNA damage response. They are mostly cell cycle specific and associate with damage sensors, signal transducers and effectors at particular phases of the cell cycle and as a consequence of these cascade events result in signal transduction specificity. ATM and ATR phosphorylates most of these mediators, the well known mediators are p53 binding protein -53bp (Wang et al., 2003), the topoisomerase binding protein - TopBP1 (Yamane et al., 2002), and mediator of DNA damage checkpoint-MDC1 (Stewart et al., 2003). Additional mediators function on cell cycle checkpoint pathways are breast cancer 1 (BRCA1) and the earlier mentioned Mre11 complex which are also involved in DNA repair (Figure 3). Similarly, the human Claspin which has sequence homology to yeast Mrc1 was originally thought to be a mediator. Based on recent studies conducted with Xenopus laveis, Claspin is an important protein required for Chk1 phosphorylation by ATR and it appears to function more like a sensor (Kumagai et al., 2000, 2003).


1.1.4. Effectors

The cell cycle checkpoint kinases Chk1 and Chk2 are two serine/threonine protein kinases (Figure 3), which target the downstream effectors of the checkpoint pathways like ATM and ATR (McGowan, 2002). In mammalian cells, both kinases play a key role in all checkpoint pathways responsive to DNA damage. The double-strand break by ionizing radiation signal sensed by ATM is transduced by Chk2 (Matsuoka et al., 2000) and the UV damage signal sensed by ATR is transduced by Chk1 (Abraham et al., 2001).

Moreover, both Chk1 and Chk2 phosphorylate have many common substrates thereby delaying or arresting the cell cycle specific stages (Walworth, 2000). In cell cycle checkpoint, one of the major targets for Chk1 and Chk2 is cell division cycle protein Cdc25, which dephosphorylates and activates Cdks (Bartek and Lukas, 2003). Functional role of Chk1 and Chk2 shows that knockout out Chk1 (-/-) causes embryonic lethality in mice (Liu et al., 2000), whereas Chk2 (-/-) knockout mice are viable and appear to exhibit near-normal checkpoint responses (Jack et al., 2002). Another investigation by Bell et al. (1999) shows that mutations in human Chk2 gene cause Li-Fraumeni-like cancer-prone syndrome, a genetic disorder that can lead to several types of cancer.

2. G1/S checkpoint

G1 cell cycle checkpoint is one of the best checkpoints in mammalian cells because it prevents the damaged DNA from being replicated by activating the checkpoint kinases. In G1, this whole process prevents the entry of damaged DNA into S phase. Figure 4 shows the two successive cell cycle checkpoint responses at G1/S which depends on the kind of DNA damage. For instance, if the DNA damage is double-strand breaks caused by ionizing radiation, which leads to phosphorylation of ATM that subsequently phosphorylates Chk2. Single-strand gaps result in the activation of Rad17-RFC, the 9-1-1 complex, and ATR, which leads to phosphorylation of Chk1.

DNA damage response operates via post-translational modification, which activates both Chk1 and Chk2 kinases, which further phosphorylate the Cdc25A phosphates (Lukas and Bartek, 2003). Cdc25A phosphorylation is inactivated by nuclear exclusion and ubiquitin mediated proteolysis (Busino et al., 2004). Study from Falck (2001) demonstrated that the lack of Cdc25A leads to addition of the phosphorylated form of Cdk2. Phosphorylation of Cdk2 inhibits the loading of Cdc45 onto chromatin and thereby prevents the initiation of DNA replication (Falck et al., 2001).

In contrast to Cdc25A, G1/S arrest is also regulated by p53. Both ATM and ATR phosphorylated p53 directly on Ser15 and indirectly on Ser20 via activation by phosphorylation of Chk2 and Chk1 respectively (Abraham, 2001). The phosphorylation of p53 inhibits its nuclear export resulting in increased levels of p53 (Zhang et al., 2001). The activation of p53 increases the transcription of p21, the inhibitor of cyclin-dependent kinases, CDKs (Ryan et al., 2001). p21 (WAF-1/Cip1) also binds to the Cdk4-CyclinD complex and prevents it from phosphorylating Rb (Harper et al., 1993). In its unphosphorylated form, Rb binds the E2F transcription factor of S-phase genes and thereby prevents the transition to S-phase (Harbour and Dean, 2000). In case of the continued existence of DNA damage in G1, p53 can induce apoptosis or the cell can enter senescence (Kohn and Pommier, 2005).

3. Intra-S phase checkpoint

The intra-S phase checkpoint comprises a large set of checkpoint and repair proteins. During DNA replication and repair processes in S-phase, cell either repair the DNA damage before the DNA polymerase encounters the DNA lesion, or the cell may allow bypass of the lesion and restore the DNA later. In the former state, DNA replication will slow down because of the DNA repair and in the latter state cell cycle arrest will allow the DNA repair.

The damage sensors for the intra-S checkpoint encompass a large set of checkpoint and repair proteins. It has been shown that when the damage is double-strand break or a double-strand break resulting from the replication of a nicked or gapped DNA the ATM M/R/N complex and BRCA1 are required for the activation of the checkpoint (Howlett et al., 2002). Two pathways are mediated when the S-phase checkpoint is initiated by double-strand breaks.

Firstly, the well understood ATM-Chk2-Cdc25A-Cdk2 pathway undergoes a checkpoint response. In S-phase this pathway delays replication by blocking the loading of Cdc45 onto chromatin that in turn attracts DNA polymerase-[alpha] as a consequence it extends the DNA replication time allowing DNA repair to take place. The second pathway of S-phase checkpoint is independent of Cdc25A (Figure 5), but requires the activities of ATM which expressed one or more inactive dimers that undergo autophosphorylation (Bakkenist et al., 2003). Activated ATM rapidly phosphorylates the C-terminal tail of histone H2A variant H2AX tagging DNA double-strand breaks and forming the initial signal for the subsequent migration of other checkpoint proteins (Stucki et al., 2005). The localization of MDC1 with H2AX is necessary for the recruitment of 53BP1, BRCA1 and the Mre11-NBS1-Rad50 complex. ATM-dependent phosphorylation of BRCA1, NBS1 and two additional players in the NBS1 branch of the pathway the SMC1, a chromosomal structural maintenance protein and FANCD2, a Fanconi anemia complementation group D2 protein, both are needed for an intact intra-S phase checkpoint (Shiloh et al., 2003; Andrea et al., 2003). Mutation in NBS1 gene results in Nijmegen breakage syndrome. As mention earlier, NSB1 forms a complex with Mre11 and Rad50 along with H2AX at DNA damage sites. Formation of this complex structure results in DNA double-strand break repair by HR (Sakamoto et al., 2007).


4. G2/M checkpoint

In G2/M checkpoint, if the cell bypasses S-phase with damaged DNA, the G2/M checkpoint stops the cell cycle in order to prevent the cell from entering mitosis. As in previous G1/S checkpoint the kind of DNA damage determines the pathways. In G2/M checkpoint DNA damage caused by IR induced double-strand breaks which activate the ATM -Chk2-Cdc25 pathway. DNA damage created by UV light activates ATR-Chk1-Cdc25 pathway (Figure 6) to arrest the cell cycle (Donzelli et al., 2003; Sancar et al., 2004). In any event, checkpoint kinases inhibit the entry into mitosis by down-regulating Cdc25 and up-regulating Wee1, which together control Cdc2/CyclinB activity (Boutros et al. 2006). Initially, it was thought that Cdc25C is the effector of G2/M checkpoint (Peng et al., 1997). Chen et al. (2001) found that mouse Cdc25C knockout cells have a normal G2/M checkpoint. In contrast, disruption of the Chk1-Cdc25A pathway by withdrawing ionization-radiation induced S and G2 checkpoint, indicating that Cdc25A phosphatase is the main effector of the G2/M checkpoint (Zhao et al., 2002). Upon phosphorylation, the Cdc25 phosphatase binds to the 14-3-3 proteins and becomes set apart in the cytoplasm and degraded by the ubiquitin-proteasome pathway (Peng et al., 1997).


In addition to the checkpoint kinases, checkpoint mediators such as a BRCA1, 53BP1, and MDC1 are involved in the G2/M checkpoint. On the other hand p53, a tumor suppressor protein has been shown to participate in the G2/M checkpoint (Stewart et al. 2003), just as in the G1/S checkpoint. P53 is involved in maintenance rather than in the initiation of G2 cell cycle arrest. For instance, wild-type p53 HCT116 cells were able to sustain a G2 arrest in response to IR. Whereas, the isogenic p53 -null derivative (copied) arrested initially in G2 but then escaped and entered mitosis (Bunz et al., 1998). Further study of p53 has to be carried out in the G2/M checkpoint in response to DNA damage by IR and UV respectively.

5. DNA repair mechanisms

DNA damage checkpoints which involved in a cascade of proteins that can only prevent the transduction of mutations to daughter cells by means of efficient DNA damage repair machinery. As there are many different lesions possible, DNA repair pathways can be divided into five categories:

(i) direct repair,

(ii) base excision repair (BES),

(iii) nucleotide excision repair (NER),

(iv) mismatch repair (MMR),

(v) double-strand break repair (DSBR).

(i) Direct repair

Ultraviolet radiation range of 200-300 nanometers is harmful to the biological functions of DNA. The action of UV-irradiation results in the formation of cyclobutane thymine dimers which are the major photoproducts in the DNA damage (Heelis et al., 1993). Most of the organisms have two direct repair mechanisms: The most direct form of DNA repair mechanism is the photo-reactivation of UV-induced pyrimidine dimmers by DNA photolyase. Another form of direct repair mechanism is by removal of the methyl group from DNA by O (6)-methylguanine-DNA methyltransferase. It is important to note that photolyase is not present in many species including humans, whereas methylguanine DNA methyltransferase has nearly universal distribution in nature (Sancar et al., 1994).


(i-a) Photolyase is a monomeric protein of 55- 65 kDa with two chromophore cofactors, a pterin in the form of 5-10-methenyltetrahydrofolate

(MTHF) and a flavin in the form of [FADH.sup.-] (Sancar et al., 1994). Current data supports the following major steps in the photorepair mechanism. The photolyase enzyme binds to the dimer in a (UV-visible) photon and the MTHF cofactor absorbs a blue light photon and then excites [FADH.sup.-] by energy transfer (Figure 7). The excited [FADH.sup.-] transfers an electron to split the dimer and the electron is transferred back to photolyase to regenerate [FADH.sup.-] and the enzyme dissociate from the repaired DNA.

(i-b) O6-methylguanine-DNA-methyltransferase

(MGMT), also called O6-alkylguanine DNA alkyltransferase, is a DNA repair protein of about 20 kDa that does not contain a cofactor and is ubiquitously found in prokaryotic and eukaryotic organisms (Figure 8) (Sancar et al., 2004). The MGMT enzyme removes mutagenic and cytogenic adducts from O6-guanine in DNA, via a one-step methyl transfer reaction (Lindahl et al., 1988). During this alkylation process on DNA, the methyl group is transferred from alkylated base onto a cysteine residue in the active site of MGMT by blocking DNA replication (Erickson et al., 1980). The inactivated alkyl-MGMT protein is then degraded in an ATP-dependent ubiquitin proteolytic pathway (Srivenugopal et al., 1996). MGMT has been shown to prevent mutations in a number of target genes including the p53 genes (Hussain et al., 1994) and the Ras oncogene (Esteller et al., 2000).

(ii) Base excision repair

Base excision repair is a multi-step process that corrects non-bulky damage to bases resulting from oxidation, methylation, deamination, or spontaneous loss of the DNA base itself (Memisoglu et al., 2000). A recent study has identified the importance of this pathway by inactivating the BER core proteins in mice leads to embryonic lethality (Houtgraaf et al., 2006). BER has two subpathways: both of these pathways initiated by the action of a DNA glycosylase that cleaves the N-glycosidic bond between the damaged base and the sugar phosphate backbone of the DNA (Figure 9). This cleavage generates an apyrimidinic/apurinic (AP) in the DNA which is substrate for the single-patch repair pathway. In the alternative long-patch repair, AP endonuclease (APE) cuts the sugar phosphate backbone of to the AP site

(Sancar et al., 2004). The single-patch, one-nucleotide gap is filled in by DNA polymerase-[beta]

(Pol[beta]) and subsequently ligated by the ligase3/XRCC1 complex. Unlike single-patch repair, the long-patch repair is PCNA-dependent pathway (Frosina, 1996) in which the involvement of DNA polymerase-[beta] and DNA polymerase [delta]/[epsilon] as well as the FEN1 endonuclease adds several nucleotide to remove the displaced DNA flap and DNA ligase1 for sealing the backbone of the DNA double helix.


(iii)Nucleotide Excision Repair (NER)

NER is the most important repair system to remove bulky DNA lesions that can be caused by UV radiation (Cyclobutane-Pyrimidine-dimers) and 6-4PP (pyrimidine-6-4-pyrimidone photoproducts) other NER substrates include bulky chemical adducts, DNA intra-strand crosslinks, and some forms of oxidative damage are the results of NER (Hess et al., 1997).



The NER mechanism consists of a multistep process (Boer and Hoeijmakers, 2000). Numerous proteins are required for the action of NER that includes damage recognition, local opening of the DNA duplex around the lesion, dual incision of the damaged DNA strand, gap repair synthesis, and strand ligation (Batty, 2000). In prokaryotes, only three proteins (UvrA, UvrB and UvrC) are required in NER, while more than 30 proteins are involved in the mammalian NER (Truglio et al., 2006). During NER, the damage DNA is recognized by the following binding proteins such as RPA, XPA, and XPC-TFIIH which assemble at the damage site in a random order. These multiple protein repair factors form a complex at the binding site and if the binding site is damage-free ATP hydrolysis by the XPB and XPD helicases dissociate the complex (Figure 10). If the site contains a lesion, ATP hydrolysis unwinds the duplex by about 25 bp around the lesion making a stable preincision complex 1 (PIC1) at the damage site. If the complex binds at damaged site XPG replaces XPC and making more stable pre-incision complex 2 (PIC2). Finally, XPF.ERCC1 is recruited to the damage site to form pre-incision complex 3 (PIC3). The endonuclease XPG and ERCC1/ XPF then cleave one strand of the DNA at positions 3' and 5' by generating an approximately 24-32 base oligonucleotide. The resulting 24-32 oligonucleotide is released and the gap is filled by DNA polymerase [delta]/[epsilon] with the aid of replication accessory proteins PCNA and RFC.

Knowledge of human NER has been gained through the study of two human genetic syndromes, Xeroderma pigmentosum (XP) (Petit and Sancar, 1999) and Cockayne syndrome (CS) (Hanawalt et al., 2002). These diseases are characterized by neuro-degeneration resulting in increased cancer frequency and ageing. XP is caused by defect in one of two genes XPA to XPG whereas, CS is caused by defect in one of two genes (CSA or CSB) (Thoms et al., 2007). The XP gene products are now known to perform various functions during damage recognition and DNA incision (Lindahl, 1999). On the other hand, the CS gene products are required for NER-based repair of transcriptionally active genes (Friedberg, 1996).


(iv)Mismatch repair

Mismatch repair (MMR) systems is a multistep process that play an important role in promoting genetic stability by repairing DNA replication errors such as, base-base mismatches (A-G or C-T) and insertion /deletion loops (IDLs) that result from DNA polymerase misincorporation of nucleotide and template slippage, respectively (Harfe and Jinks-Robertson, 2000). DNA MMR proteins were first derived from studies of E. coli and it shows that MMR proteins are highly conserved process from prokaryotes to eukaryotes (Obmolova et al., 2000). For instance, there are three major MMR proteins constituted in vitro: MutS, MutL, and MutH. MutS is an ATPase dependent protein that homodimerizes the base/base mismatch or insertion/deletion loops (IDLs).

Unlike bacterial MMR system, the mammalian MMR system contains proteins related to the bacterial MutS and MutL proteins but is more complex than the bacterial system. It involves two different heterodimeric complexes of MutS-related proteins, MSH2-MSH6 (known as MutS[alpha]) and MSH2-MSH3 (known as MutS[beta]), and each has different mispair recognition specificity (Genschel et al., 1998) (Figure 11). However, the MSH2-MSH6 focuses on the recognition of heterodimers single base-base mismatches and small insertion/deletion loops (IDLs). Whereas, MSH2-MSH3 recognizes the larger loops (2-10 bases). Most (80-90%) of the MSH2 in the cell is complexed with MSH6 to form MutS[alpha]. Thus, MutS[beta] is a relatively minor activity. Similarly, instead of a single MutL-related protein, mammalian MMR involves a heterodimeric complex of two MutL-related proteins, MLH1-PMS1 (PMS2 in humans) (Kolodner et al., 2002). Heterodimeric complexes of MLH1/PMS2 (MutL[alpha]) and MLH1/PMS1 (MutL[beta]) interact with MSH complexes and replication factors (Buermeyer et al., 1999). Excision and re-synthesis of the nascent strand (containing the mismatch or IDL) is performed by a number of proteins including PCNA (Proliferating Cell Nuclear Antigen), RPA (Replication Protein-A), RFC (Replication Factor-C) Exonuclease-I, DNA Polymerases Delta/Epsilon, Endonuclease FEN1 (Flap structure-specific Endonuclease-1), and additional factors (Buermeyer et al., 1999). According to studies published, defects in MMR genes cause a predisposition to hereditary non-polyposis colorectal carcinoma (HNPCC) (Fishel et al., 1993). Patient affected with HNPCC tumor shows the occurrence of instability of simple repetitive DNA sequences (microsatellite instability or MSI). Statistical analysis has shown that more than 90% of the colorectal tumors and at least 75% of the endometrial tumors from HNPCC patients display MSI (Leeuw et al., 2000).


(v) Double strand breaks

As previously mentioned, IR induces a large variety of DNA lesions especially double strand breaks are considered to be the most lethal lesions (Bradley and Kohn, 1979). DSBs are repaired by two pathways: the so-called homologous recombination (HR) or non-homologous end-joining (NHEJ) (Figure 12) (Kanaar et al., 1998). Vertebrates cells preferentially repair DSBs by HR in the late-S and G2 phases of the cell cycle when an undamaged sister chromatid is available, while NHEJ appears to be confined mainly to the G1/early-S phases (Takata et al., 1998).

(v-a) Homologous recombination of DSB

Homologous recombination repair of DSBs is essential for making error-free genetic information from a homologous undamaged DNA molecule. The majority of HR repair is mediated by Rad52 epistasis group that includes the Rad51, Rad52, Rad54, Rad55, Rad57, MRE11 and NBS1 function in the initial sensor of the broken DNA ends (Sonoda et al., 2001). Processing of the damaged ends ensue the production of 3' ssDNA overhangs. Strand invasion and branch migration is initiated by Rad51 in eukaryotes (Sung, 1994), or RecA in prokaryotes (Cox et al., 2002). Other proteins including RPA (Replication Protein-A), Rad52, Rad54, BRCA1, BRCA2 (Breast Cancer Susceptibility Proteins) and several additional Rad51-related proteins serve as accessory factors in filament assembly and subsequent Rad51 activities (Jackson, 2002) (Figure 12). The Rad51 nucleoprotein filament then searches the undamaged DNA on the sister chromatid for a homologous repair template. Upon identification of homologous template, damaged DNA strand invades the undamaged DNA duplex by a process called DNA strand exchange. A DNA polymerase then extends the 3' end of the invading strand and subsequent ligation by DNA ligase-I yields a hetero-duplexed DNA structure. This recombination intermediate is resolved and the precise error-free correction of the DSB is complete.

(v-b) Non-homologous end-joining of DSB

Non-homologous end-joining (NHEJ) is the most preferred repair mechanism of DSB repair in mammalian cells (Jeggo, 1998). In contrast to HR, this pathway does not require homology and can rejoin broken DNA ends directly end-to-end. The activity of the Ku70/Ku80 heterodimeric protein is essential to the NHEJ pathway. The Ku heterodimer initiates NHEJ by binding to the free DNA ends and recruiting other NHEJ factors such as DNA-Pk (DNA-dependent protein kinase), XRCC4 to XRCC7 and DNA Ligase-IV (Figure 12). In addition to the Ku and Ligase-IV homologs, the Rad50, MRE11 and NBS1 genes are also involved in NHEJ (Huang et al., 2002). DNA-Pk becomes activated upon DNA binding, and phosphorylation of these factors facilitates the repair process.

6. Role of BRCA1-2 and RAD51 in response to DNA damage

Epidemiological studies show that breast cancer is the most common cancer among women worldwide with a yearly incidence of over 1 million (Mcpherson et al., 2000). Breast cancer type-1 and 2 (BRCA1) and (BRCA2) are normal genes carried by all men and women; when functioning properly, these genes help to prevent cells from growing out of control. In this article, we summarize some of the structural and functional role of BRCA1-2 and Rad51 in response to DNA damage.

6.1 The BRCA1 gene

The genetic identification of breast cancer gene has become established over the past two decades with the cloning of two major breast cancer genes BRCA1 and BRCA2 (Wooster et al., 1995). In 1994, BRCA1 gene was cloned and mapped on chromosome 17q21 by genetic linkage analysis. BRCA1 gene encodes a protein which consists of 1863 amino acid sequence with approximately 208 kDa and is expressed in most proliferating cells (Figure 13-A). The COOH-terminus of BRCA1 protein contains an amino acid sequence motif known as BRCT domain. The BRCT domain in the COOH-terminus of BRCA1 seems to be an important protein interaction domain for many DNA repair proteins. It interacts with the BRCA1-associated RING finger domain protein (BARD1) (Jensen et al., 1998) which is required for ubiquitin ligase activity, the MRE11/RAD50/NBS1 (M/R/N) recombination repair complex, a putative DNA helicase BRCA1-associated C-terminal Helicase (BACH1) (Cantor et al., 2001), the CtBp-interacting protein CtIP (Kaelin et al., 1990) and RNA polymerase II (Scully et al., 2000). In the NH-terminus, there is a ring domain for protein-protein interaction but this domain is also involved in protein ubiquitination.

6.2 The BRCA2 gene

BRCA2 gene is very large and mapped on chromosome 13q 12-13. This gene encodes a 3418 amino acid sequence protein which is approximately 385 kDa (Figure 13-B). BRCA2 is characterized by a very large exon11, which encodes peptide motifs required for the interaction with Rad51 protein (Chen et al., 1999). Rad51 is the eukaryotic homology of the prokaryotic recombination protein ReCA and is located at chromosome position 15q15.1 (Takahashi et al., 1994). Rad51 proteins colocalize with Rad52 (Essers et al., 2002), Rad54 (Essers et al., 2002), the single -strand binding protein RPA (Raderschall et al., 1999) and the tumor suppressor proteins BRCA1 and BRCA2 as mentioned above. BRCA2 interacts with the histone acetylase P/CAF (Scully and Livingston, 2000) BRCA2-associated factor BRAF35 and DSS1. The sites of the eight BRC repeats, six of which interact with Rad51, the oligonucleotide binding (OB) domain that interacts with single-stranded DNA and the carboxyterminal NLS (nuclear localization signal) are indicated.



6.3 BRCA2 regulates Rad51 to mediate recombination

BRCA2 plays an important role in the regulating of DSBs repair by homologous recombination, a pathway which is dependent upon the recombinase function of Rad51 (Moynahan et al., 2001). It has been shown that there is a direct interaction between BRCA2 and Rad51 and their co-localization in nuclear foci after DNA damage. This represents the role of BRCA2 within this DNA repair pathway (Chen et al., 1998). Yuan et al. (1999) showed that cell lines defective in BRCA2 fail to accumulate Rad51 foci after DNA damage treatment. The structural detail shows that BRCA2 has two distinct Rad51 binding domains in which the first domain consists of a set of eight 35-residue motifs located in the central region of the protein, encoded by exon 11 of the BRCA2 gene (Chen et al., 1998). BRCA2 also binds Rad51 via a C-terminal motif that is unrelated to the BRC repeats and encoded within exon 27 (Christopher et al., 2007).

BRCA2 contains eight BRC repeats in which BRC3 and BRC4 have the strongest interaction with Rad51 with the exception of BRC5 and BRC6 (Bignell et al., 1997). Pellegrini (2002) showed that the crystal structure of the BRC4 peptide sequence (amino acids 1517-1551) of BRCA2 is bound to Rad51. This structure demonstrates a series of hydrophobic and hydrophilic interactions involving the hairpin structure of BRC4 created by the short anti-parallel beta-sheets and alpha-helix. In vitro study had suggested that BRC3 or BRC4 peptides could inhibit the formation of Rad51 complexes (Davies et al., 2001). However, in living cells the effect of full-length BRCA2 is to promote homologous recombination (Moynahan et al., 2001). On the other hand, the expression of the BRC4 peptide inhibits BRCA2 homologous recombination (Xia et al., 2001) and the same observation of interaction between Rad51 and BRC3 or BRC4 inhibiting the DNA binding are also observed by Tarsounas et al. (2004). The formation of Rad51 foci require BRCA2 and BRCA1 (Yuan et al., 1999), especially after exposure to ionizing radiation.


These observations have created a question: Why does the BRC4 peptide inhibit filament formation but the whole BRCA2 protein appears to promote filament formation? Answer to this question is - the BRC4 region of BRCA2 interacts with Rad51 such that it prevents Rad51 monomer-monomer interaction, which in turn blocks filament formation on DNA (Davies et al., 2001; Pellegrini et al., 2002). In contrast to BRC, the BRCA2 acts as a loading factor for Rad51 on ssDNA by means of its BRC peptide interaction. As the Rad51 bound to BRCA2 finds its position adjacent to a Rad51 monomer on ssDNA, the monomer-monomer interaction becomes favored over the BRCA2 interaction as we know that the Rad51-dependent homologous recombination and Rad51 filament formation in S-phase occurs in the absence of BRCA2. However, the presence of BRCA2 is required to prevent major errors, such as chromosome aberrations, which occur in BRCA2-deficient cells (Patel et al., 1998). In contrast to the interaction of BRCA2, the region encompassing residues 758-1064 in BRCA1 was first reported to be involved in its interaction with Rad51 (Scully et al., 2000). But it remains unclear, however, whether the two proteins can bind directly.

6.4 Rad51 foci

Immunohistochemistry is the good source of identifying nuclear foci in response to DNA damage. Recombination protein machinery are normally found in the nucleus, they are diffused throughout the nucleus and are rapidly re-localized and concentrated into sub-nuclear complex that are microscopically detected as foci. Results from Tarsounas et al. (2004) showed the formation of repair foci in response to ionizing radiation when culture cells were analyzed for the presence of Rad51 foci by using immune-fluorescence staining, approximately 10-15% of the cells were found to contain Rad51 foci (Figure 14, non-irradiated cells). These are thought to represent the population of cells in the culture that are undergoing S phase and are actively replicating their DNA. When the treatment of cells was followed by 10 Gy (a unit of ionizing radiation), the number of cells containing Rad51 foci increased to more than 50% (Figure 14, irradiated cells).

7. Conclusion

Based on all evidences and observations over the past 30 years, our knowledge about DNA damage, DNA damage checkpoints and DNA repair has increased. In spite of this, there is still a clear need for finding the missing components and connections in the network of the checkpoint signaling. Also, the DNA repair mechanism needs to be analyzed as the concept of DNA damage checkpoint and DNA repair mechanism is very important for our understanding for the treatment of cancer and chemotherapy. More recently, it was reported that a DNA repair biomarkers would provide crucial information on the status of various cancer progression. Therefore, further study is warranted to develop a better functional DNA repair biomarkers for the early detection of quantitative and qualitative analysis for various cancers which could be useful in therapies.


Based on the evidence presented in this review, it is seen that BRCA1/BRCA2 and Rad51 play a central role in homologous recombination. However, the precise role of BRCA1 and BRCA2 as a tumor suppressor is not fully understood. Although, the current knowledge illustrates that cancer cells without a functional BRCA1/2 proteins are resistant to anti -microtubule drug-based chemotherapy, they are sensitive to DNA damaging agents that cause DSBs (ionizing radiation) and inter strand cross- linking agents such as platinum-based drugs (cisplatin and carboplatin). Therefore, it is important to identify the functional role of BRCA1 and BRCA2 proteins which will then be helpful in designing specific drugs in targeting solid tumors.

Understanding the protein-protein interaction also plays a central role in approaching new chemotherapy. Therefore, it is important to know the key role of Rad51 interaction with BRCA2, which acts as a cofactor in homologous recombination. As such, the role of Rad51-dependent homologous recombination constitutes a key function in DNA damage. Based on this interaction, structural models that give a detailed understanding of Rad51 activation and its function can be improved. This might be helpful in improving the design of drugs which can modulate the Rad51 activity and improve the efficacies of radiation therapy and chemotherapy.

Conflict of Interests

None declared.


We are thankful to Dr. Aziz Sancar, Department of Biochemistry and Biophysics, University of North Carolina School of Medicine, USA and Dr. Stephen C West (FRS), London Research Institute, Clare Hall Laboratories, UK for giving us the permission to use some of their images for this review article.


Abraham RT, 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes and Development, 15: 2177-2196.

Bakkenist CJ, Kastan MB, 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 421: 499-506.

Batty DP, Wood RD, 2000. Damage recognition in nucleotide excision repair of DNA. Gene, 241: 193.

Bartek J, Lukas J, 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, 3: 421-429.

Boutros R, Dozier C, Ducommun B, 2006. The when and wheres of CDC25 phosphatases. Current Opinion in Cell Biology, 18: 185-191.

Becker WM, Kleinsmith LJ, Hardin J, 2006. The World of the Cell, 6th ed; Pearson Benjamin Cummings: San Francisco. pp 307-309.

Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, 1999. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science, 286: 2528-2531.

Bignell G, Micklem G, Stratton MR, Ashworth A, Wooster R, 1997. The BRC repeats are conserved in mammalian BRCA2 proteins. Human Molecular Genetics, 6: 53-58.

Bray CM, West CE, 2005. DNA repair mechanisms in plants: crucial sensors and effectors for the maintenance of genome integrity. New Phytologist, 168: 511-528.

Buermeyer AB, Deschenes SM, Baker Liskay RM, 1999. Mammalian DNA mismatch repair. Annual Review of Genetics, 33: 533-564.

Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282: 1497-1501.

Busino L, Chiesa M, Draetta GF, Donzelli M, 2004. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene, 23: 2050-2056.

Cantor SB, Bell DW, Ganesan S, Kass EM, Drapkin R, Grossman S, 2001. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell, 105: 149-160.

Chen CF, Chen PL, Zhong Q, Sharp ZD, Lee WHJ, 1999. Expression of BRC repeats in breast cancer cells disrupts the BRCA2-Rad51 complex and leads to radiation hypersensitivity and loss of G2/M checkpoint control. Biological Chemistry, 274: 32931-32935.

Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, et al. 1998. Stable interaction of the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Molecular Cell, 2: 317-328.

Chen MS, Hurov J, White LS, Woodford-Thomas T, Piwnica-Worms H, 2001. Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Cell Biology, 21: 3853-3861.

Christopher J, Ashworth LA, 2007. RAD51, BRCA2 and DNA repair: a partial resolution. Natural, Structural & Molecular Biology, 4: 461-462.

Cimprich KA, Shin TB, Keith CT, Schreiber SL, 1996. cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proceedings of National Academy of Sciences, 93: 2850-2855.

Cortez D, Wang Y, Qin J, Elledge SJ, 1999. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science, 286: 1162-1166.

Davies AA, Masson JY, McIlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR, 2001. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Molecular Cell, 7: 273-282.

D'Andrea AD, Grompe M, 2003. The Fanconi anaemia/BRCA pathway. Nature Reviews Cancer, 3: 23-34.

De Boer J, Hoeijmakers JH, 2000. Nucleotide excision repair and human syndromes. Carcinogenesis, 21: 453-460.

De Klein A, Muijtjens M, van Os R, Verhoeven Y, Smit B, Carr AM, 2000. Targeted disruption of the cell cycle checkpoint gene ATR leads to early embryonic lethality in mice. Current Biology, 10: 479-482.

de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, 2000. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. Journal of Pathology, 192: 328-335.

Erickson LC, Laurent G, Sharkey NA, Kohn KW, 1980. DNA cross-linking and monoadduct repair in nitrosourea treated human tumor cells. Nature, 288: 727-729.

Essers J, Houtsmuller AB, van VL, Paulusma C, Nigg AL, Pastink A, et al., 2002. Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO Journal, 21(8): 2030-2037.

Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, 2000. Inactivation of the DNA repair gene O6-Methylguanine-DNA Methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Research, 60: 2368-2371.

Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J, 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature, 410: 842-847.

Friedberg EC, 1996. Cockayne syndrome, a primary defect in DNA repair, transcription, both or neither? BioEssays, 18: 731.

Frosina G, Fortini P, Rossi O, Carrozzino F, Raspaglio G, Cox LS, 1996. Two pathways for base excision repair in mammalian cells. Journal of Biological Chemistry, 271: 9573.

Genschel J, Littman SJ, Drummond JT, Modrich P, 1998. Isolation of hMutS from human cells and comparison of the mismatch specificities of hMutSb and hMutSa. Journal of Biological Chemistry, 273: 19895-19901.

Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D, 2003. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature, 421: 952-956.

Harbour JW, Dean DC, 2000. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes and Development, 14: 2393-2409.

Harfe BD, Jinks-Robertson S, 2000. DNA mismatch repair and genetic instability. Annual Review of Genetics, 34: 359-399.

Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816.

Heelis P, Kim S, Okamura T, Sancar A, 1993. The photo repair of pyrimidine dimers by DNA photolyase and model systems. Journal of Photochemistry and Photobiology B: Biology, 17: 219-228.

Hess MT, Schwitter U, Petretta M, Giese B, Naegeli H, 1997. Bipartite substrate discrimination by human nucleotide excision repair. Proceedings of National Academy of Sciences, 94: 6664.

Houtgraaf JH, Versmissen J, van der Giessen WJ,, 2006. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovascular Revascularization Medicine, 7: 165-172.

Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297: 606-609.

Hussain SP, Aguilar F, Cerutti P, 1994. Mutagenesis of codon 248 of the human p53 tumor suppressor gene by N-ethyl-N-nitrosourea. Oncogene, 9: 13-18.

Jack MT, Woo RA, Hirao A, Cheung A, Mak TW, Lee PWK, 2002. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response. Proceedings of National Academy of Sciences, 99: 9825-9829.

Jeggo PA, 1998. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiation Research, 150: S80-91.

Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, et al., 1998. A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene, 16: 1097-1112.

Kaelin WG, Ewen ME, Livingston DM, 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Molecular Cell Biology, 10: 3761-3769.

Kanaar R, Hoeijmakers JH, Van Gent DC, 1998. Molecular mechanisms of DNA double strand break repair. Trends in Cell Biology, 8: 483-489.

Kolodner RD, Putnam CD, Myung K, 2002. Maintenance of genome stability in Saccharomyces cerevisiae. Science, 297: 552-557.

Kumagai A, Dunphy WG, 2000. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Molecular Cell, 6: 839-849.

Lindahl T, Wood RD, 1999. Quality control by DNA repair. Science, 286: 1897-1905.

Liu Y Maizels N.Liu Yilun, Maizels Nancy, 2000. Coordinated response of mammalian Rad51 and Rad52 to DNA damage. EMBO Reports, 1: 85-90.

Lukas C, Falck J, Bartkova J, Bartek J, Lukas J, 2003. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nature Cell Biology, 5: 255-260.

McGowan CH, 2002. Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor. BioEssays, 24: 502-511.

Melo J, Toczyski D, 2002. A unified view of the DNA-damage checkpoint. Current Opinion in Cell Biology, 14: 237-245.

Memisoglu A, Samson L, 2000. Base excision repair in yeast and mammals. Mutation Research, 451: 39-51.

Moynahan ME, Pierce AJ, Jasin M, 2001. BRCA2 is required for homology-directed repair of chromosomal breaks. Molecular Cell, 2: 263-272.

Nasmyth K, 1996. Viewpoints: Putting the cell cycle in order. Science, 274: 1643-1645.

Obmolova G, Ban C, Hsieh P, Yang W, 2000. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature, 407: 703-710.

Patel KJ, Vu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, 1998. Involvement of Brca2 in DNA Repair. Molecular Cell, 1: 347-357.

Peng CY, Graves PR, Thoma RS, Wu ZQ, Shaw AS, Piwnica-Worms H, 1997. Mitotic and G2 checkpoint control: regulation of 14- 3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277: 1501-1505.

Petit C, Sancar A, 1999. Nucleotide excision repair: from E. coli to man. Biochimie, 81: 15-25.

Petrini JH, Stracker TH, 2003. The cellular response to DNA double-strand breaks: Defining the sensors and mediators. Trends in Cell Biology, 13: 458-462.

Pellegrini L, 2002. Insights into DNA recombination from the structure of a Rad51-BRCA2 complex. Nature, 420: 287-293.

Powell SN, Kachnic LA, 2003. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene, 22: 5784-5791.

Raderschall E, Golub EI, Haaf T, 1999. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proceedings of National Academy of Sciences. 96: 1921-1926.

Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038.

Ryan KM, Phillips AC, Vousden KH, 2001. Regulation and function of the p53 tumor suppressor protein. Current Opinion in Cell Biology, 13: 332-337.

Sakamoto S, Iijima K, Mochizuki D, 2007. Homologous recombination repair is regulated by domains at the N-and C-terminus of NBS1 and is dissociated

with ATM functions. Oncogene, 26: 6002-6009.

Sancar A, 1994. Structure and function of DNA photolyase. Biochemistry, 33: 2-9.

Sancar A, Lindsey-Boltz LA, Unsal -Kacmaz K, Linn S, 2004. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry, 73: 39-85.

Schultz LB, Chehab NH, Malikzay A, Halazonetis TD, 2000. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. Journal of Cell Biology, 151: 1381-1390.

Scully R, Livingston DM, 2000. In search of the tumor-suppressor functions of BRCA1 and BRCA2. Nature, 408: 429-432.

Shiloh Y, 1997. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annual Review of Genetics, 31: 635-662.

Shinohara A, Ogawa H, Ogawa T, 1992. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell, 3: 457-470.

Srivenugopal KS, Yuan XH, Friedman HS, Ali-Osman F, 1996. Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis (2- chloroethyl) -1-nitrosourea. Biochemistry, 35: 1328-1334.

Stewart GS, Wang B, Bignell CR, Taylor AMR, Elledge SJ, 2003. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature, 421: 961-966.

Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP, 2005. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell, 123: 1213-1226.

Sung P, 1994. Catalysis of ATP-dependent homologous DNA pairing and strand exchange by yeast RAD51 protein. Science, 265: 1241-1243.

Takahashi E, Matsuda Y, Hori T, Yasuda N, Tsuji S, Mori M, 1994. Chromosome mapping of the human (RECA) and mouse (Reca) homologs of the yeast RAD51 and Escherichia coli recA genes to human (15q15.1) and mouse (2F1) chromosomes by direct R-banding fluorescence in situ hybridization. Genomics, 19: 376-378.

Tarsounas M, Davies AA, West SC, 2004. RAD51 localization and activation following DNA damage. Philosophical Transactions of the Royal Society B: Biological Sciences, 359: 87-93.

Thoms KM, Kuschal C, Emmert S, 2007. Lessons learned from DNA repair defective syndromes. Experimental Dermatology, 16: 532-544.

Truglio JJ, Croteau DL, Van Houten B, Kisker C, 2006. Prokaryotic nucleotide excision repair: the UvrABC system. Chemical Reviews, 106: 233-252.

Walworth NC, 2000. Cell-cycle checkpoint kinases: checking in on the cell cycle. Current Opinion in Cell Biology, 12: 697-704.

Wang D, Hara R, Singh G, Sancar A, Lippard SJ, 2003. Nucleotide excision repair from site-specifically platinum-modified nucleosomes. Biochemistry, 42: 6747-6753.

Xia F, Taghian DG, DeFrank JS, Zeng ZC, Willers H, Iliakis G, 2001. Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proceedings of National Academy of Sciences, 98: 8644-8649.

Yamane K, Wu X, Chen J, 2002. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Molecular Cell Biology, 22: 555-566.

Zhang YP, Xiong Y, 2001. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science, 292: 1910-1915.

Zhao H, Watkins JL, Piwnica-Worms H, 2002. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proceedings of National Academy of Sciences, 99: 14795-14800.

M Asimuddin, K Jamil*

Centre for Biotechnology and Bioinformatics, School of Life Sciences, Jawaharlal Nehru Institute of Advance Studies, Buddha Bhavan, MG Road, Secunderabad, Andhra Pradesh, India.

*Corresponding Author:

Accepted: 11th Sep 2012, Published: 28th Sep 2012
COPYRIGHT 2012 HATASO Enterprises, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Asimuddin, M.; Jamil, K.
Publication:Biology and Medicine
Article Type:Report
Geographic Code:9INDI
Date:Oct 1, 2012
Previous Article:Ameliorative effect of Vitamin E on the deleterious effect of Amodiaquine hydrochloride (AQ.HCl) on the reproductive function of the adult cyclic...
Next Article:Inhalant allergens in respiratory disorders: comparative study on the intradermal skin testing, IgE levels and spirometry in South Indian population.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters